Understanding Asian Patient Experience at MD Anderson
This observational study at MD Anderson aims to understand the experiences of Asian cancer patients during their inpatient care. Researchers want to learn what helps and what creates challenges for a positive patient experience. They will also gather insights from healthcare providers about their perceptions of Asian patients' experiences. The study is looking for 520 participants, including former Asian/Asian American cancer patients who received inpatient care at MD Anderson between 2019 and 2022, are 18 or older, have a U.S. address, and can read English or simplified Chinese. The main goal is to identify key aspects of inpatient experience for these patients, measured using a questionnaire (PPE-15) over about one year. This study does not involve any new drugs or treatments.
- Study design
- This is an observational study, meaning it gathers information without testing a specific intervention. It plans to enroll 520 participants.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will be followed through study completion, which is an average of one year.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Understanding Patient Experience Among Asians at MD Anderson
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Lorna McNeill, MPH,PHD · PRINCIPAL_INVESTIGATOR · M.D. Anderson Cancer Center
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
What this trial measures
- Picker Patient Experience Questionnaire (PPE-15)Through study completion; an average of 1 year